tian wen shu - Net Worth and Insider Trading

tian wen shu Net Worth

The estimated net worth of tian wen shu is at least $164 Million dollars as of 2024-11-13. tian wen shu is the Supervisors of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd and owns about 4,796,900 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) stock worth over $164 Million. Details can be seen in tian wen shu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that tian wen shu has not made any transactions after 2023-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of tian wen shu

tian wen shu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, tian wen shu owns 1 companies in total, including Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) .

Click here to see the complete history of tian wen shu’s form 4 insider trades.

Insider Ownership Summary of tian wen shu

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300937	Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd	2023-11-24	Supervisors

tian wen shu Latest Holdings Summary

tian wen shu currently owns a total of 1 stock. tian wen shu owns 4,796,900 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) as of November 24, 2023, with a value of $164 Million.

Latest Holdings of tian wen shu

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300937	Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd	2023-11-24	4,796,900	34.15	163,814,135

Holding Weightings of tian wen shu

tian wen shu Form 4 Trading Tracker

According to the SEC Form 4 filings, tian wen shu has made a total of 4 transactions in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd is the sale of 260,000 shares on November 24, 2023, which brought tian wen shu around $10 Million.

Insider Trading History of tian wen shu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

tian wen shu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

tian wen shu Ownership Network

Ownership Network List of tian wen shu

No Data

Ownership Network Relation of tian wen shu

tian wen shu Owned Company Details

What does Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd do?

Who are the key executives at Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd?

tian wen shu is the Supervisors of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd. Other key executives at Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd include Executives Lei Qi Gang , and Directors & Directors & and Executives Hao Rui Zhi .

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) Insider Trades Summary

Over the past 18 months, tian wen shu made 4 insider transaction in Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) with a net sale of 1,203,000.

In summary, during the past 3 months, insiders sold 0 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,203,000 shares of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,203,000 shares.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd Insider Transactions

No Available Data

tian wen shu Mailing Address

Above is the net worth, insider trading, and ownership report for tian wen shu. Currently GuruFocus does not have mailing address information for tian wen shu.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.